Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Cytovia presents new series of caspase activators and apoptosis inducers

July 4, 2001

Nippon Shinyaku to market and distribute DepoCyt in Japan

July 4, 2001

Gene and cell cycle effects elucidated for NB-1011

July 4, 2001

SafeScience to create joint venture with Elan for phase II anticancer agent

July 3, 2001

Additional beneficial effects emerge for SERM Sch-57068 (EM-652) in preclinical studies

July 3, 2001

ImClone Systems begins fast track approval process for colorectal cancer agent

July 3, 2001

Liver-targeted complexes of cisplatin and bile acids designed by Spanish group

July 3, 2001

FDA grants fast track designation for irofulven in pancreatic cancer

July 2, 2001

Mode of action of Oxigene's CA4P supported by preclinical data

July 2, 2001

Matrix commences new phase II IntraDose study for primary liver cancer

July 2, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 5, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...